Thursday, February 24, 2011
Florence, Palazzo Vecchio – Salone dei Cinquecento

MENARINI RESEARCH: TODAY’S VALUES, TOMORROW’S CHALLENGES

• "Welcome" by MATTEO RENZI (Mayor of the city of Florence)

• "Company’s Opening Address" by LUCIA ALEOTTI (Member of Menarini Administrative Committee)

• Video “125 Years of Menarini”

• Address by GIANFRANCO GENSINI (Dean of the School of Medicine, University of Florence)

• Address by di ENRICO GARACI (President of the Higher Institute of Health – Rome)

• Address by SERGIO DOMPE’ - President of Farmindustria

• "Today’s Values and Tomorrow’s Challenges for MENARINI Research" by CARLO ALBERTO MAGGI (Director of Research for the Menarini Group)

• "Nitric Oxide: The Road to Stockholm" by LOUIS J. IGNARRO (Nobel Prize Laureate in Medicine and Physiology Professor of Molecular and Medical Pharmacology U.C.L.A., Los Angeles, California – U.S.A.)

• "Abagovomab, the Immunotherapy for Ovarian Cancer: Can We Increase Survival?" by JONATHAN S. BEREK
  (Professor and Chair, Obstetrics and Gynaecology Stanford Women’s Cancer Center, Stanford University School of Medicine,
  Stanford, California – U.S.A)

• "From Protocol to Clinical Trials: The Commitment of Menarini Research in the MIMOSA Project" by ANGELA CAPRIATI (Director of Clinical Research for the Menarini Group)

• "Italian Research on Neuropeptides: An Area of Excellence" by DOMENICO REGOLI (Department of Clinical and Experimental Medicine, University of Ferrara)

• "Focus on Biotechnology" by ANDREW SLADE (President of Menarini Biotech)